Compare Nutanix Inc (NTNX) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Sana Biotechnology Inc — how do they compare? Nutanix Inc trades at $53.61 (market cap $14.90B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Nutanix Inc is far larger — about 17.1× Sana Biotechnology Inc's market cap, and Nutanix Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| NTNX | SANA | |
|---|---|---|
Market Cap | $14.90B | $873.84M |
Sector | Technology | Health |
52-Week High | $81.12 | $5.92 |
52-Week Low | $34.41 | $2.68 |
Enterprise Value | $14.41B | $848.03M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
